Cargando…

Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats

Context: Berberine is an active alkaloid isolated from Rhizoma coptidis [Coptis chinensis Franch. (Ranunculaceae)] that is widely used for the treatment of diabetes, hyperlipidemia and hypertension. However, the pharmacokinetics of berberine in normal rats and type 2 diabetes mellitus (T2DM) model r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yuzhen, Xu, Binger, Xu, Jisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130524/ https://www.ncbi.nlm.nih.gov/pubmed/27937081 http://dx.doi.org/10.1080/13880209.2016.1255649

Ejemplares similares

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
por: Han, Yunfeng, et al.
Publicado: (2021)

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
por: Mi, Jia, et al.
Publicado: (2019)

Application of Berberine on Treating Type 2 Diabetes Mellitus
por: Pang, Bing, et al.
Publicado: (2015)

Effects of berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
por: Xin, Hua-Wen, et al.
Publicado: (2016)

Effects of Berberine and Hwangryunhaedok-Tang on Oral Bioavailability and Pharmacokinetics of Ciprofloxacin in Rats
por: Hwang, Youn-Hwan, et al.
Publicado: (2012)

Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
por: Dong, Hui, et al.
Publicado: (2012)

Berberine in Combination with Insulin Has Additive Effects on Titanium Implants Osseointegration in Diabetes Mellitus Rats
por: Lu, Li, et al.
Publicado: (2015)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
por: Feng, Xinchi, et al.
Publicado: (2021)

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
por: Gong, Jing, et al.
Publicado: (2017)

Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
por: Li, Zheng, et al.
Publicado: (2014)

Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
por: He, Qiongyao, et al.
Publicado: (2022)

Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats
por: Zhao, Jin-Dong, et al.
Publicado: (2021)

Pharmacokinetic Comparison of Berberine in Rat Plasma after Oral Administration of Berberine Hydrochloride in Normal and Post Inflammation Irritable Bowel Syndrome Rats
por: Gong, Zipeng, et al.
Publicado: (2014)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
por: Zhang, Shichang, et al.
Publicado: (2022)

Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
por: Wang, Kun, et al.
Publicado: (2023)

Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine
por: Buchanan, Beth, et al.
Publicado: (2018)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
por: Xie, Wenting, et al.
Publicado: (2022)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
por: Xue, Mei, et al.
Publicado: (2013)

Exploratory Pharmacokinetics of Geniposide in Rat Model of Cerebral Ischemia Orally Administered with or without Baicalin and/or Berberine
por: Pan, Linmei, et al.
Publicado: (2013)

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
por: Zhang, Yifei, et al.
Publicado: (2020)

The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine
por: Ma, Xueling, et al.
Publicado: (2018)

Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus
por: Melin, Johanna, et al.
Publicado: (2022)

Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review
por: Cortez-Navarrete, Marisol, et al.
Publicado: (2023)

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
por: Iijima, Hiroaki, et al.
Publicado: (2015)

Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus
por: Li, Ling, et al.
Publicado: (2020)

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
por: Sahasrabudhe, V., et al.
Publicado: (2017)

Berberine protects against metformin-associated lactic acidosis in induced diabetes mellitus
por: Almani, Suhail Ahmed, et al.
Publicado: (2017)

Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients
por: Memon, Muhammad Ayoob, et al.
Publicado: (2018)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
por: Xia, Xuan, et al.
Publicado: (2011)

Berberine is sufficient to restore the destroyed seminiferous tubule structure and hypospermatogenesis in diabetes mellitus
por: Gao, Xintao, et al.
Publicado: (2020)

Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway
por: Wu, Yang Sheng, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
por: Di Bisceglie, Adrian M., et al.
Publicado: (2020)

Effect of Qufengtongluo Decoction on PI3K/Akt Signaling Pathway in the Kidney of Type 2 Diabetes Mellitus Rat (GK Rat) with Diabetic Nephropathy
por: Huang, Wei-Jun, et al.
Publicado: (2018)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
por: Kwon, Mihwa, et al.
Publicado: (2020)

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus
por: Dudkowski, Caroline, et al.
Publicado: (2016)

Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus
por: Morello, Candis M
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e7kimbr8gtb6cmv20ofqfqf0jv